Cargando…
TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in Chinese city of Wuhan has caused around 906,092 deaths and 28,040,853 confirmed cases worldwide (https://covid19.who.int/, 11 September 2020). In a life-threatening situation, where there is no specific and licensed...
Autores principales: | Ansari, Mohammad Azam, Jamal, Qazi Mohammad Sajid, Rehman, Suriya, Almatroudi, Ahmad, Alzohairy, Mohammad A., Alomary, Mohammad N., Tripathi, Takshashila, Alharbi, Ali H., Adil, Syed Farooq, Khan, Mujeeb, Shaheer Malik, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of King Saud University.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527303/ https://www.ncbi.nlm.nih.gov/pubmed/34909057 http://dx.doi.org/10.1016/j.arabjc.2020.09.037 |
Ejemplares similares
-
Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
por: Jamal, Qazi Mohammad Sajid, et al.
Publicado: (2021) -
Natural Products and Nutrients against Different Viral Diseases: Prospects in Prevention and Treatment of SARS-CoV-2
por: Ali, Syed Ghazanfar, et al.
Publicado: (2021) -
Polyphenols and Their Nanoformulations: Protective Effects against Human Diseases
por: Anand, Santosh, et al.
Publicado: (2022) -
Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents
por: Ansari, Mohammad Azam, et al.
Publicado: (2021) -
Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic
por: Muteeb, Ghazala, et al.
Publicado: (2020)